Please check the following:
- {{x.value}}
FREE membership
FREE membership
Join Intelligent Investor today
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
Please enter the 5 digit verification code sent to "{{user.DayPhone}}" Change number
We cannot send you a verification code via SMS to "{{user.DayPhone}}" Change number
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
Please enter your mobile number and press send to receive a text message with a verification code.
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
Thank you
We have sent you an email with the details of your registration.
Purchase order
Sign up
Log in
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Log in
Upgrade Today
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
{{eventFunction.Name}}
{{eventFunction.EventTypeName}}
{{eventFunction.StartDate}}
{{eventFunction.EventTimings}}
{{eventFunction.VenueName}}
{{ t.Cost === 0 ? "FREE" : "$" + t.Cost.toFixed(2) }}
Quantity *
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
Congratulations!
You now have free access to InvestSMART, we look forward to helping you on your financial journey.
You now have access to Free Eureka Report Insights, We look forward to helping you on your financial journey.
You now have access to Intelligent Investor Free Insights. We look forward to helping you build a market beating stock portfolio.
Looking for more…
Intelligent Investor Membership
15-day Free Trial
- Indepth analysis of ASX listed shares
- BUY, Hold and Sell Recommendations
- Ideas Lab
- Special Reports
No thanks
Looking for more…
Eureka Report Membership
15-day Free Trial
- Alan Kohler’s Weekend Briefing
- Interviews with CEO’s & top influencers
- Money Cafe and Talking Finance
- Super Advice and Q&A with Ask Alan
No thanks
Vita Life Sciences Limited (ASX: VLS) - Share Price and Research
Current share price for VLS : $2.340 0.01 (0.43%)
Vita Life Sciences Limited (VLS), an ASX-listed company, has a business of development and distribution of over the counter medicines, complementary and alternative medicines, dietary supplements and health foods under various brand names throughout Australia, South East Asia and China. Over 400 registered products, and around 300 employees. The Company have teams of qualified naturopaths, nutritionists, biotechnologists and pharmacists formulating products that are clean & functional.
VLS General Information +
| ASX Code | VLS |
| Website | http://www.vitalifesciences.com |
| Industry/Sector | Pharmaceuticals |
| Market Cap ($M) | 130 |
| VLS Share Price | $2.340 |
| Day High | $2.340 |
| Day Low | $2.340 |
| Last Close | $2.330 |
| VLS Share Price Movement | $0.01 ( 0.43% ) |
Prices as at 16:35, 16 Apr 2024
+Security prices are delayed by at least 20 minutes and are indicative only.
VLS Related Research
Vita Life Sciences Limited (VLS) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| HFResult | 6¢ | 100% | 22 Mar 2024 | 12 Apr 2024 | $2.340 | $2.280 | 3.86% |
| Result | 3¢ | 100% | 22 Sep 2023 | 6 Oct 2023 | $2.340 | $2.280 | 3.86% |
| HFResult | 3.25¢ | 100% | 17 Mar 2023 | 14 Apr 2023 | $2.340 | $2.280 | 3.86% |
See all dividends from Vita Life Sciences Limited (VLS) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Vita Life Sciences Limited (VLS) Recent ASX Announcements
| Headline | Annoucement date/time+ | Price at announcement+ | Current price+ | Price 7D Avg | Gain/Loss |
|---|---|---|---|---|---|
| Notification of cessation of securities - VLS | 12 Apr 2024 12:56PM | $2.340 | $2.340 | $2.280 | fallen by 0% |
| Capital Update-Vested Plan Shares | 11 Apr 2024 11:54AM | $2.400 | $2.340 | $2.280 | fallen by 2.50% |
| Cleansing Statement | 11 Apr 2024 11:51AM | $2.400 | $2.340 | $2.280 | fallen by 2.50% |
- + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.
See all ASX announcements from Vita Life Sciences Limited (VLS) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.
VLS Financial Summary
| Year to Dec | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2023A | $9.08 | $16.60 | 26.50% | 9.50 | 9.00 | 5.70% | 100.0% |
| 2022A | $7.34 | $13.10 | -16.00% | 14.30 | 6.00 | 3.20% | 100.0% |
| 2021A | $8.25 | $15.60 | 34.80% | 8.00 | 5.80 | 4.60% | 100.0% |
VLS Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2021 A | 2022 A | 2023 A | 2021 A | 2022 A | 2023 A | 2021 A | 2022 A | 2023 A | ||
| Mayne Pharma Group (MYX) | $601M | 0.9287 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Neuren Pharmaceuticals (NEU) | $2,651M | 799.6667 | -0.5504 | 0.6667 | 17.2856 | 38.4444 | 23.0667 | 0.00% | 0.00% | 0.00% |
| Vita Life Sciences (VLS) | $129M | 0.2652 | 0.0000 | 0.0000 | 13.9157 | 0.0000 | 0.0000 | 3.90% | 0.00% | 0.00% |
VLS Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.27 | 14.00 | 3.03 | 0.00 |
| Market | 0.50 | 15.10 | 1.12 | 1.04 |
| Sector | 1.28 | 21.50 | 2.00 | 0.98 |
VLS Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Andrew O'Keefe | Managing Director | 24 Oct 2016 |
| Mr Jack Teoh | Non-Executive Director | 30 Sep 2022 |
| Mr Peter Osborne | Non-Executive Director | 1 Aug 2023 |
| Mr Henry George Townsing | Non-Executive Director, Non-Executive Chairman | 22 Dec 2011 |
Vita Life Sciences Limited (VLS) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 27 Mar 2024 | TOWNSING, Henry | Transfer | Indirect Shares | 300,000 | $1.890 | $567,000.000 |
| 27 Mar 2024 | TOWNSING, Henry | Transfer | Direct Shares | 300,000 | $1.890 | $567,000.000 |
| 12 Mar 2024 | OSBORNE, Peter | Buy | Direct Shares | 10,000 | $2.250 | $22,500.000 |
See all changes in directors' interest & trades for Vita Life Sciences Limited (VLS) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
VLS Management
| Name | Position |
|---|---|
| Chin Leng Khoo | Chief Financial Officer,Company Secretary |
| Chin L Khoo | Company Secretary, Chief Financial Officer |
VLS Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Vita Life Sciences Limited (VLS). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 8,551,439 (15.10%) | Chemical Trustee Limited |
| 8,435,693 (14.90%) | Vicky Teoh |
| 7,371,832 (13%) | Barings Acceptance Limited |
| 6,276,040 (11.10%) | Anglo Australian Christtan and Charitable Fund |
| 4,340,366 (7.70%) | Tie Lim Sung |
VLS Calendar of Events
| Date | Event |
|---|---|
| 17 March 2025 | Report (Annual) |
| 24 February 2025 | Report (Prelim) |
| 22 August 2024 | Report (Interim) |
| 16 April 2024 | Issued Shares |
FAQs about Vita Life Sciences Limited (VLS)
What is the current share price of Vita Life Sciences Limited (VLS)?
Vita Life Sciences Limited's (VLS) current share price is $2.34. This constitutes a price movement of 2.63% when compared to the share price 7 days ago and is -4.88% below VLS's 12-month high of $2.46 per share. Prices are delayed by at least 20 minutes.
What is the share price movement for Vita Life Sciences Limited (VLS)?
Relative to the previous close share price of $2.33, Vita Life Sciences Limited's (VLS) current share price of $2.34 constitutes a movement of $0.01 or 0.43%. Vita Life Sciences Limited's (VLS) share price movement is 2.63% when compared to 7 days ago and is -4.88% below VLS's 52-week high of $2.46.
What is the 52-week high share price for Vita Life Sciences Limited (VLS)?
Vita Life Sciences Limited's (VLS) 52-week high is $2.46 which was reached on 18 Mar 2024. Relative to this, VLS's current share price of $2.34 constitutes a -$0.12 or -4.88% drop since that high of $2.46 per VLS share.
What is the 52-week low share price for Vita Life Sciences Limited (VLS)?
Vita Life Sciences Limited's (VLS) 52-week low is $1.42 which was reached on 17 Apr 2023. Relative to this, VLS's current share price of $2.34 constitutes a $0.92 or 64.79% gain since that low of $1.42 per VLS share.
What is the daily average trading volume for Vita Life Sciences Limited (VLS)?
Over the last 12 months, Vita Life Sciences Limited (VLS) has a daily average trading volume of 7,263 VLS shares per day.
What is the dividend yield for Vita Life Sciences Limited (VLS)?
Vita Life Sciences Limited (VLS) has a current dividend yield of n/a this year. Last year's dividend yield was 5.10%. The dividend yield for VLS is a ratio that tells you the percentage of Vita Life Sciences Limited's (VLS) share price that it pays out in dividends each year.
What was Vita Life Sciences Limited (VLS) last dividend payment?
Vita Life Sciences Limited (VLS) last dividend payment was $0.06 per share and was paid on 12 Apr 2024. This last VLS dividend included 100% franking.
When does Vita Life Sciences Limited (VLS) release its next Annual Report?
Vita Life Sciences Limited (VLS) will release its next Annual Report on 17 March 2025. Vita Life Sciences Limited's (VLS) last annual report was released on 18 Mar 2024. Click here to view Vita Life Sciences Limited's (VLS) last annual report.
In which sector is Vita Life Sciences Limited (VLS) classified?
Vita Life Sciences Limited (VLS) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), ResMed Inc. (RMD), Cochlear Limited (COH), and Fisher & Paykel Healthcare Corporation Limited (FPH).
What is the price-to-earnings (P/E) ratio for Vita Life Sciences Limited (VLS)?
The price-to-earnings (P/E) ratio for Vita Life Sciences Limited (VLS) is 14. The price-to-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of Vita Life Sciences Limited's (VLS) share price to its earnings per VLS share.
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
